Rekombinanter TNF alpha (Infliximab Biosimilar) Antikörper

Produktnummer ABIN7515732

Produktdetails anti-TNF alpha (Infliximab Biosimilar) Antikörper

Target: TNF alpha (Infliximab Biosimilar)

Antikörpertyp: Recombinant Antibody

Reaktivität: Human

Wirt: Maus

Klonalität: Monoklonal

Konjugat: Dieser TNF alpha (Infliximab Biosimilar) Antikörper ist unkonjugiert

Applikation: Western Blotting (WB)

Verwendungszweck: Recombinant mouse monoclonal antibody raised against human TNF alpha.

Spezifität: Binds to soluble and transmembrane forms of TNF-alpha and neutralizes its biological activity. Does not bind to TNF-beta.

Kreuzreaktivität: Human

Immunogen: Original antibody is raised against purified recombinant human TNF (rTNF).

Klon: CA2

Isotyp: IgG2a

Anwendungsinformationen

Applikationshinweise: Western Blot,The optimal working dilution should be determined by the end user.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: In PBS with 0.02 % Proclin 300.

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.

Details zu TNF alpha (Infliximab Biosimilar)

Target: TNF alpha (Infliximab Biosimilar)

Abstract: TNF alpha (Infliximab Biosimilar) Produkte

Synonyme: DIF antikoerper, TNF-alpha antikoerper, TNFA antikoerper, TNFSF2 antikoerper, tumor necrosis factor antikoerper, TNF antikoerper

Substanzklasse: Biosimilar

Hintergrund: Tumor necrosis factor (TNF superfamily, member 2)

Gen-ID: 7124